Amgen Shareholder Cuts Stake, Other Hedge Funds Boost Holdings
Meyer Handelman Co., a financial firm, sold shares of Amgen Inc. (NASDAQ:AMGN) in the second quarter, reducing its position by 4.0%.
The company now owns 111,120 shares of Amgen's stock after selling 4,645 shares during the period.
This reduction makes up 1.1% of Meyer Handelman Co.'s holdings, and the total value of its Amgen shares is $40,238,000 at the end of the quarter.
Other hedge funds have also made changes to their positions in Amgen during this period, including TCW Group Inc., Fulton Breakefield Broenniman LLC, BIP Wealth LLC, and Trifecta Capital Advisors LLC.